A new study has found that 1 in 5 survivors of COVID-19 develop mental illness within 90 days of contracting the disease, with patients being diagnosed with severe mood disorders, even in individuals that had no prior history of these conditions. Other neurological effects have included vivid hallucinations, even amongstread more
The United States recorded the largest single-day increase in COVID-19 cases on October 23, logging nearly 84,000 new cases, higher than the previous single-day peak reached in July. Sixteen individual states are reporting sharp increases in hospitalization rates, and health experts warn that the worst is yet to come, forecastingread more
A large-scale clinical trial conducted by the World Health Organization has determined that Gilead Sciences Inc.’s remdesivir had little or no effect on COVID-19 patients’ chances of survival or length of hospital stay. The antiviral drug had been granted Emergency Use Authorization (EUA) by the Food and Drug Administration inread more
As tenacious and pervasive as the coronavirus at the root of our long-running pandemic appears to be, SARS-CoV-2 has not only a host of strengths aiding its spread, but it also hides numerous vulnerabilities that could be exploited to help contain and defeat the deadly pathogen. Aside from lastingread more